NDC 42291-970 – Zafirlukast
Zafirlukast 10 mg/1 · Tablet, Coated · Oral
Product NDC42291-970
Product details
- Brand name
- Zafirlukast
- Generic name
- Zafirlukast
- Labeler
- AvKARE
- Dosage form
- Tablet, Coated
- Route
- Oral
- Marketing category
- NDA · NDA020547
- Marketed since
- April 5, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Leukotriene Receptor Antagonist
Active ingredients
- Zafirlukast 10 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42291-970-60 | 60 TABLET, COATED in 1 BOTTLE (42291-970-60) | Apr 5, 2023 |
Other Zafirlukast products
- 42291-971 Zafirlukast 20 mg/1 · Tablet, Coated · AvKARE
- 64380-187 Zafirlukast 10 mg/1 · Tablet, Coated · Strides Pharma Science Limited
- 64380-188 Zafirlukast 20 mg/1 · Tablet, Coated · Strides Pharma Science Limited
- 68084-059 Zafirlukast 20 mg/1 · Tablet, Film Coated · American Health Packaging
- 59651-291 Zafirlukast 10 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 59651-292 Zafirlukast 20 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 72162-2361 Zafirlukast 20 mg/1 · Tablet, Film Coated · Bryant Ranch Prepack
- 31722-007 Zafirlukast 10 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-008 Zafirlukast 20 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 55111-625 Zafirlukast 10 mg/1 · Tablet, Film Coated · Dr. Reddys Laboratories Limited
- 55111-626 Zafirlukast 20 mg/1 · Tablet, Film Coated · Dr. Reddys Laboratories Limited